Resistance to Antiretroviral Drugs: A Threat to the Prevention and Treatment of Pediatric HIV Infection

Krogstad, Paul A.
May 2007
Journal of Infectious Diseases;5/15/2007, Vol. 195 Issue 10, p1393
Academic Journal
The article presents a study on resistance to antiretroviral drugs, a threat to the prevention and treatment of pediatric human immunodeficiency virus (HIV) infection. Mother-to-child transmission (MTCT) of HIV were recognized as signatures of HIV infection in infants. Nucleoside analogue reverse-transcriptase inhibitor (NRTI) antiretroviral therapy delayed the progression of disease and zidovudine caused the improvements in cognitive function.


Related Articles

  • The Time to Treat the Children Is Now. Adams, Lisa V.; Palumbo, Paul // Journal of Infectious Diseases;5/15/2007, Vol. 195 Issue 10, p1396 

    The article offers information in treating children with human immunodeficiency syndrome (HIV). Infants and children born to HIV-infected parents face threat for the disease. Of the 39.5 million people living with acquired immuno deficiency syndrome(AIDS) globally, 2.3 million were 15 years old....

  • Eliminating Vertically-transmitted HIV/AIDS while Improving Access to Treatment and Care forWomen, Children and Adolescents in Jamaica. Christie, C. D. C.; Pierre, R. B. // West Indian Medical Journal;Jul2012, Vol. 61 Issue 4, p396 

    Background and Methods: To celebrate Jamaica's 50th birthday after receiving independence from Great Britain, we summarize our collaborative published research in the prevention, treatment and care of paediatric, perinatal and adolescent HIV/AIDS in Jamaica. Results: Public access to...

  • Identification of human immunodeficiency virus-1 (HIV-1) transmission from a 29-year-old daughter to her mother in Shanghai, China. Shao, Jiasheng; Chen, Jun; Shen, Yinzhong; Wang, Jiangrong; Zhang, Renfang; Zheng, Yufang; Liu, Li; Wang, Zhenyan; Lu, Hongzhou // Archives of Virology;Jan2013, Vol. 158 Issue 1, p11 

    Background and methods: Routes of intrafamilial transmission of HIV-1 are not always clear. Here, we describe transmission to a mother from her 29-year-old daughter within a family setting through clinical, epidemiological and molecular evidence. We evaluated the risk factors for intrafamilial...

  • Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission--Thailand, 1996-1998. Vuthipongse, P.; Bhadrakom, C.; Chaisilwattana, P.; Roongpisuthipong, A.; Chalermchokcharoenkit, A.; Chearskul, S.; Wanprapa, N.; Chokephaibulkit, K.; Tuchinda, M.; Wasi, C.; Chuachoowong, R.; Siriwasin, W.; Chinayon, P.; Asavapiriyanont, S.; Chotpitayasunondh, T.; Waranawat, N.; Sangtaweesin, V.; Horpaopan, S. // JAMA: Journal of the American Medical Association;4/8/98, Vol. 279 Issue 14, p1061 

    Examines the use of zidovudine (ZDV) to prevent perinatal infection with HIV. Testing of drug in the United States and Thailand; Effects of short-term antenatal regimen of ZDV; Methods used in research; Data collected; Estimated HIV transmission risk; Importance of study; Shorter regimen...

  • Antiretroviral Therapy as HIV Prevention: Status and Prospects. Mayer, Kenneth H.; Venkatesh, Kartik K. // American Journal of Public Health;Oct2010, Vol. 100 Issue 10, p1867 

    As antiretroviral treatment of HIV infection has become increasingly accessible, attention has focused on whether these drugs can used for prevention because of increased tolerability of newer medications, decreased cost, and the limitations of other approaches. We review the status of...

  • The Effects of Fetal and Childhood Exposure to Antiretroviral Agents. Mas, Catherine M.; Miller, Tracie L.; Cordero, Christina; Dauphin, Danielle; White, Marie Boursiquot; Vila, Christie K.; Somarriba, Gabriel; Wilkinson, James D.; Lipshultz, Steven E. // Journal of AIDS & Clinical Research;Special2012, Vol. 3 Issue S, Special section p1 

    Purpose: The compliant use of combination antiretroviral therapy has virtually eliminated perinatal HIV transmission. Although antiretroviral drug toxicities in adults have been well documented, the effects of fetal and early childhood exposure to antiretroviral drugs on children of HIV-positive...

  • Beginning to Make Progress against HIV. Wilfert, Catherine M. // New England Journal of Medicine;11/28/96, Vol. 335 Issue 22, p1678 

    Opinion. Discusses efforts to reduce perinatal human immunodeficiency virus (HIV) infection. Evidence of the preventive efficacy of zidovudine demonstrated by Sperling et al.; How Sperling's work, called Protocol 076, is being implemented in the United States; Details of three studies...

  • Short-Course Antenatal Zidovuine Reduces Both Cervicovaginal Human Immunodeficiency Virus Type 1... Chuachoowong, Rutt; Shaffer, Nathan; Young, Nancy L.; Mock, Philip A.; Chearskul, Sanay; Waranawat, Naris; Chaowanachan, Thongpoon; Karon, John; Simonds, R.J.; Mastro, Timothy D. // Journal of Infectious Diseases;1/1/2000, Vol. 181 Issue 1, p99 

    Evaluates the interrelationship among HIV-1 levels in cervicovaginal lavage and plasma, zidovudine treatment and risk of perinatal transmission. Determinants of HIV transmission; Risk factors associated with perinatal transmission; Duration of membrane rupture.

  • Pharmacological and clinical evidence of nevirapine immediate-and extended-release formulations. Ena, Javier; Amador, ConcepciĆ³n; Benito, Conxa; Pasquau, Francisco // HIV/AIDS - Research & Palliative Care;2012, Vol. 4, p169 

    We reviewed the current information available on nevirapine immediate- and extended-release formulations and its role in single-dose and combination antiretroviral therapy. Nevirapine was approved in 1996 and was the first non-nucleoside reverse-transcriptase inhibitor available for the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics